Japan
Our partner depot in Japan spans an impressive 1.2 million sq.m., with 300,000 sq.m. dedicated to pharmaceutical products. Prioritising sustainability, the facility features solar power generation systems and nighttime heat storage air conditioning across all offices.
Capabilities
  • Partner depot in Japan obtained Green Management Certificate.
  • Global logistics network with depots and cold chain infrastructure.
  • Facilities comply with GDSP and GMP standards and offer advanced temperature control technology for cold chain solutions.
  • Smart Sourcing Solution for exclusive access to medicines and controlled drugs.
  • High standards of quality maintained, meeting GDP, GMP, CSV, and HSE requirements.
Opportunities
  • Japan's ¥10-trillion (USD 75B) national endowment fund signals growth in healthcare industry.
  • Japan accounts for 4.7% of global clinical trial activity in 2022.
  • Japan's developed healthcare system and ageing population increase demand for new treatments.
  • Sakigake package accelerates drug and device approvals in Japan.
  • Japanese Ministry of Health promotes innovation in pharmaceutical manufacturing.